Axsome Therapeutics (AXSM) News Today $125.68 -3.61 (-2.79%) Closing price 04:00 PM EasternExtended Trading$127.08 +1.40 (+1.12%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AXSM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Scientech Research LLC Purchases Shares of 9,759 Axsome Therapeutics, Inc. $AXSMSeptember 9 at 5:58 AM | marketbeat.comAdage Capital Partners GP L.L.C. Sells 12,000 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 9 at 4:41 AM | marketbeat.comAxsome Therapeutics, Inc. (AXSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 8 at 5:49 PM | seekingalpha.comEventide Asset Management LLC Sells 83,861 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 6 at 8:27 AM | marketbeat.comMark Saad Sells 9,127 Shares of Axsome Therapeutics (NASDAQ:AXSM) StockSeptember 6 at 8:10 AM | insidertrades.comCormorant Asset Management LP Trims Stock Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 6 at 7:45 AM | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Raised to Strong-Buy at Wells Fargo & CompanySeptember 6 at 6:34 AM | marketbeat.comCanada Pension Plan Investment Board Purchases 40,400 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 6 at 4:58 AM | marketbeat.comIeq Capital LLC Purchases New Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 6 at 4:35 AM | marketbeat.comBVF Inc. IL Increases Stock Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 5, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Upgraded at Wells Fargo & CompanySeptember 5, 2025 | americanbankingnews.comAxsome Therapeutics (AXSM) Has a New Rating from Wells FargoSeptember 4, 2025 | theglobeandmail.comAxsome Therapeutics (NASDAQ:AXSM) Director Sells $1,665,227.52 in StockSeptember 4, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Director Roger Jeffs Sells 13,464 SharesSeptember 4, 2025 | americanbankingnews.comAxsome initiated with Overweight at Wells Fargo on Alzheimer's drug potentialSeptember 3, 2025 | msn.comAxsome Therapeutics assumed with an Overweight at Wells FargoSeptember 3, 2025 | msn.comPDT Partners LLC Purchases 47,004 Shares of Axsome Therapeutics, Inc. $AXSMSeptember 3, 2025 | marketbeat.comPoint72 Europe London LLP Cuts Holdings in Axsome Therapeutics, Inc. $AXSMSeptember 3, 2025 | marketbeat.comRoger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) StockSeptember 3, 2025 | insidertrades.comAxsome Therapeutics, Inc. $AXSM Shares Sold by Russell Investments Group Ltd.September 3, 2025 | marketbeat.com5,417 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Landscape Capital Management L.L.C.September 2, 2025 | marketbeat.comH.C. Wainwright Reaffirms Buy on Axsome (AXSM) Following Generic Challenge to PortfolioSeptember 2, 2025 | uk.finance.yahoo.com214,139 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by Driehaus Capital Management LLCSeptember 1, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Director Sells $2,432,000.00 in StockSeptember 1, 2025 | americanbankingnews.comTema Etfs LLC Takes $271,000 Position in Axsome Therapeutics, Inc. $AXSMAugust 31, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Holdings Trimmed by Tri Locum Partners LPAugust 30, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Director Roger Jeffs Sells 20,000 SharesAugust 30, 2025 | insidertrades.comFORA Capital LLC Purchases New Shares in Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.comNorthern Trust Corp Has $47.93 Million Stock Holdings in Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.comRaymond James Financial Inc. Sells 19,511 Shares of Axsome Therapeutics, Inc. $AXSMAugust 30, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Buy" by BrokeragesAugust 30, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Shares Bought by Affinity Asset Advisors LLCAugust 28, 2025 | marketbeat.comSynovus Financial Corp Buys 5,425 Shares of Axsome Therapeutics, Inc. $AXSMAugust 28, 2025 | marketbeat.com5,259 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Quantitative Investment Management LLCAugust 28, 2025 | marketbeat.comCapital Fund Management S.A. Takes Position in Axsome Therapeutics, Inc. $AXSMAugust 28, 2025 | marketbeat.comMetLife Investment Management LLC Has $20.87 Million Stake in Axsome Therapeutics, Inc. $AXSMAugust 27, 2025 | marketbeat.com26,307 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Axiom Investors LLC DEAugust 27, 2025 | marketbeat.comAxsome Therapeutics to Participate in Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.comInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) Director Sells 16,694 Shares of StockAugust 27, 2025 | insidertrades.comAxsome Therapeutics, Inc. $AXSM Shares Sold by Hsbc Holdings PLCAugust 27, 2025 | marketbeat.com92,640 Shares in Axsome Therapeutics, Inc. $AXSM Bought by Jump Financial LLCAugust 26, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Buys New Holdings in Axsome Therapeutics, Inc. $AXSMAugust 26, 2025 | marketbeat.comEntryPoint Capital LLC Buys New Position in Axsome Therapeutics, Inc. $AXSMAugust 26, 2025 | marketbeat.com1832 Asset Management L.P. Purchases Shares of 363,200 Axsome Therapeutics, Inc. $AXSMAugust 25, 2025 | marketbeat.comAxsome Therapeutics, Inc. $AXSM Shares Bought by Wellington Management Group LLPAugust 25, 2025 | marketbeat.comCandriam S.C.A. Invests $9.32 Million in Axsome Therapeutics, Inc. $AXSMAugust 24, 2025 | marketbeat.comAxsome Therapeutics Inc (AXSM) - Investing.comAugust 23, 2025 | investing.comAtika Capital Management LLC Increases Stock Position in Axsome Therapeutics, Inc. $AXSMAugust 23, 2025 | marketbeat.comAlethea Capital Management LLC Has $77.84 Million Stock Holdings in Axsome Therapeutics, Inc. $AXSMAugust 23, 2025 | marketbeat.com25,940 Shares in Axsome Therapeutics, Inc. $AXSM Purchased by Algert Global LLCAugust 23, 2025 | marketbeat.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼1.040.70▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼2314▲AXSM Articles Average Week Get the Latest News and Ratings for AXSM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Axsome Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies JAZZ News BNTX News TEVA News GMAB News SMMT News ASND News VTRS News RDY News QGEN News BBIO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
